Message Font: Serif | Sans-Serif
 
No. of Recommendations: 1
Hey Applefoot

Can I ask, since you said you were "up with" NVGN' ideas, what you make of this $5M+ purchase from Genentec of the Brain Tumor alkylating agent.

My concern is that the $20M bank account is burning a hole in the CEO's pocket. So he spends. Genentech would never part with a useful drug; $5M is about what you'd expect to pay for a useless one.

Novogen shows the Genentech data that - at appalling quality of life - survival is prolonged a few weeks.

My question is: do they think that used with one of their other agents, it might be useful. Remember, a clinical trial would wipe out all their Cash, so it would have to be good.

Any views appreciated
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.